
Palantir Rises, Caterpillar Falls, Hims & Hers Drops on Earnings, Vertex Plunges on Drug Results
Stock Movers
00:00
Intro
This chapter analyzes recent stock performances, highlighting Palantir's growth and rising stock price attributed to its revenue gains, while Caterpillar struggles with profitability challenges. Additionally, the discussion touches on Hims & Hers, addressing its revenue volatility and potential in hormonal therapies despite recent setbacks.
Play episode from 00:00
Transcript


